Case studies · Real work, real results
See exactly what
OniX delivers
Two live examples — rare bone diseases and Hidradenitis Suppurativa — showing the depth, global reach, and BD precision of every scouting project we run.
Case study 01 · Fractional BD
Rare disease
Rare Bone Diseases
OI, Hypophosphatasia, Fibrous Dysplasia, Achondroplasia, Osteopetrosis, Heterotopic Ossification, growth plate disorders. A comprehensive global scouting project across 8 sub-disease areas.
A targeted scouting snapshot produced as part of OniX's new Fractional BD service for early-stage biotechs.
Case study 03 · Pharma & Biotech BD
Platform Techonology
Targeted Protein Degraders
ERC · NIH/NCI · UKRI/MRC · DFG · Mark Foundation · Damon Runyon · Cancer Grand Challenge
A targeted scouting snapshot produced as part of OniX's new Fractional BD service for early-stage biotechs.
Case study 05 · Fractional BD
FOP — Proof of Concept
Fibrodysplasia Ossificans Progressiva (ACVR1/ALK2 pathway)
A targeted scouting snapshot produced as part of OniX's new Fractional BD service for early-stage biotechs.
This is a POC sample. Full Starter Retainer delivers 10–15 researchers across 5–7 countries with warm introductions.
Case study 02 · Pharma & Biotech BD
Dermatology
Hidradenitis Suppurativa
A fragmented funding landscape — NIH career awards, HSF Danby grants, ZonMw, DFG, NHMRC, SNSF, CIHR, and industry co-funding — all mapped and researcher-tagged for immediate BD use.
A targeted scouting snapshot produced as part of OniX's new Fractional BD service for early-stage biotechs.
Case study 04 · Pharma & Biotech BD
Autoimmune Diseases
Autoimmune Diseases
RA, SLE, IBD, Multiple Sclerosis, Scleroderma, Type 1 Diabetes, Sjögren's Disease, and Celiac Disease — spanning the $58.5M AMP AIM consortium, LRA Innovation Awards, SRF CONQUEST platform trial, Breakthrough T1D, CCF, National MS Society, Celiac Disease Foundation, Praespero, and 15+ government agencies. The most fragmented funding landscape in immunology, unified.
A targeted scouting snapshot produced as part of OniX's new Fractional BD service for early-stage biotechs.
Every project delivers the same precision
Researcher profiles
Name · Title · Institution · Country · Email · Career stage
Project details
Funder · ID · Amount · Period · Program
MoA / modality tags
mAb · SM · Peptide · GT · CRISPR · JAK · BTK · ASO · Cell
Publications + BD notes
Recent papers with strategic relevance annotation
BD brief + triage
Top 10 targets · Landscape read · Competitive watch